|Bid||64.01 x 1800|
|Ask||64.96 x 900|
|Day's range||63.90 - 64.80|
|52-week range||57.19 - 74.12|
|Beta (5Y monthly)||0.39|
|PE ratio (TTM)||18.10|
|Earnings date||27 Jul 2022 - 01 Aug 2022|
|Forward dividend & yield||2.92 (4.53%)|
|Ex-dividend date||14 Jun 2022|
|1y target est||69.30|
JPMorgan Chase, Gilead Sciences, CSX, CVS Health and China Petroleum & Chemical have been included in this Analyst Blog.
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Gilead Sciences, Inc. (GILD) and CSX Corporation (CSX).
FOSTER CITY, Calif., May 19, 2022--Gilead Sciences, Inc. (Nasdaq: GILD) today was officially recognized as the number one philanthropic funder of HIV-related programs in a new tracking report released by Funders Concerned About AIDS (FCAA). The report, found at: https://www.fcaaids.org/inform/philanthropic-support-to-address-hiv-aids/, is released annually and is widely regarded as the most comprehensive study of its kind. It analyzes 2020 funding data (the most recent year available) revealing